Tag: Invizius
Invizius treats first patients in first-in-human phase 1 clinical study of...
Invizius has announced in a press release that the first two patients have been treated with its H-Guard priming solution in the company’s first-in-human...
Invizius appoints nephrologist Bernard Canaud to its clinical advisory board
Invizius, a biotechnology company developing treatments for patients on dialysis, announced today the appointment of Bernard Canaud to its clinical advisory board.
Canaud brings with...
Invizius receives MHRA approval to commence first-in-human clinical study of H-Guard...
Invizius has announced that it has received approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to commence its first-in-human clinical study...
Renal Interventions’ top 10 stories of June
June saw a variety of stories from across the renal world, including an in-depth interview with two of the authors of the new UK...
Invizius awarded grant to research peritoneal dialysis indication for H-Guard technology
Invizius recently announced that it has been awarded a second Biomedical Catalyst grant (Feasibility and Primer Award) by Innovate UK to research a new...